Metraipolis › archive › dc_e593a088005f

Enzyme replacement therapy (ERT) combined with transient low-dose methotrexate (TLD-MTX) results in age- and disease-dependent immune profile changes in… — Europe PMC PMID:42760993

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42760993
DOI
10.3389/fimmu.2026.1843379
License (as archived)
solo-consultazione
Archived
2026-10-16T03:21:45.249Z
SHA-256 of the archived text
b2d15cc960faf0195c7da18964dd4111a6279434b572fe86b82612812d4669d2
Stable URL of this page
https://metraipolis.com/documento/dc_e593a088005f

How to cite

Enzyme replacement therapy (ERT) combined with transient low-dose methotrexate (TLD-MTX) results in age- and disease-dependent immune profile changes in… — Europe PMC PMID:42760993 — Europe PMC (en), https://europepmc.org/article/MED/42760993 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e593a088005f (Metraipolis archive dc_e593a088005f, sha256 b2d15cc960faf0195c7da18964dd4111a6279434b572fe86b82612812d4669d2)
BibTeX
@misc{dce593a088005f,
  title = {Enzyme replacement therapy (ERT) combined with transient low-dose methotrexate (TLD-MTX) results in age- and disease-dependent immune profile changes in… — Europe PMC PMID:42760993},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42760993},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e593a088005f; sha256 b2d15cc960faf0195c7da18964dd4111a6279434b572fe86b82612812d4669d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42760993. Agents can read the archived copy with the MCP tool read_document.